582 related articles for article (PubMed ID: 24828032)
1. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence.
Wierckx K; Van Caenegem E; Schreiner T; Haraldsen I; Fisher AD; Toye K; Kaufman JM; T'Sjoen G
J Sex Med; 2014 Aug; 11(8):1999-2011. PubMed ID: 24828032
[TBL] [Abstract][Full Text] [Related]
2. Trans men can achieve adequate muscular development through low-dose testosterone therapy: A long-term study on body composition changes.
Tominaga Y; Kobayashi T; Matsumoto Y; Moriwake T; Oshima Y; Okumura M; Horii S; Sadahira T; Katayama S; Iwata T; Nishimura S; Bekku K; Edamura K; Sugimoto M; Kobayashi Y; Watanabe M; Namba Y; Matsumoto Y; Nakatsuka M; Araki M
Andrology; 2024 Apr; ():. PubMed ID: 38563871
[TBL] [Abstract][Full Text] [Related]
3. Nonprescribed hormone use and self-performed surgeries: "do-it-yourself" transitions in transgender communities in Ontario, Canada.
Rotondi NK; Bauer GR; Scanlon K; Kaay M; Travers R; Travers A
Am J Public Health; 2013 Oct; 103(10):1830-6. PubMed ID: 23948009
[TBL] [Abstract][Full Text] [Related]
4. Effects of cross-sex hormone treatment on transgender women and men.
Deutsch MB; Bhakri V; Kubicek K
Obstet Gynecol; 2015 Mar; 125(3):605-610. PubMed ID: 25730222
[TBL] [Abstract][Full Text] [Related]
5. Gonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults.
Smith KP; Madison CM; Milne NM
Pharmacotherapy; 2014 Dec; 34(12):1282-97. PubMed ID: 25220381
[TBL] [Abstract][Full Text] [Related]
6. Effects of three different testosterone formulations in female-to-male transsexual persons.
Pelusi C; Costantino A; Martelli V; Lambertini M; Bazzocchi A; Ponti F; Battista G; Venturoli S; Meriggiola MC
J Sex Med; 2014 Dec; 11(12):3002-11. PubMed ID: 25250780
[TBL] [Abstract][Full Text] [Related]
7. Endocrine management of transsexual. Hormonal profiles of serum prolactin, testosterone, and estradiol.
Futterweit W
N Y State J Med; 1980 Jul; 80(8):1260-4. PubMed ID: 6931313
[No Abstract] [Full Text] [Related]
8. Cross-sex hormone therapy in transgender persons affects total body weight, body fat and lean body mass: a meta-analysis.
Klaver M; Dekker MJHJ; de Mutsert R; Twisk JWR; den Heijer M
Andrologia; 2017 Jun; 49(5):. PubMed ID: 27572683
[TBL] [Abstract][Full Text] [Related]
9. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.
Hembree WC; Cohen-Kettenis PT; Gooren L; Hannema SE; Meyer WJ; Murad MH; Rosenthal SM; Safer JD; Tangpricha V; T'Sjoen GG
J Clin Endocrinol Metab; 2017 Nov; 102(11):3869-3903. PubMed ID: 28945902
[TBL] [Abstract][Full Text] [Related]
10. Prolactin levels during short- and long-term cross-sex hormone treatment: an observational study in transgender persons.
Nota NM; Dekker MJHJ; Klaver M; Wiepjes CM; van Trotsenburg MA; Heijboer AC; den Heijer M
Andrologia; 2017 Aug; 49(6):. PubMed ID: 27561756
[TBL] [Abstract][Full Text] [Related]
11. Differential Effects of Cyproterone Acetate vs Spironolactone on Serum High-Density Lipoprotein and Prolactin Concentrations in the Hormonal Treatment of Transgender Women.
Fung R; Hellstern-Layefsky M; Tastenhoye C; Lega I; Steele L
J Sex Med; 2016 Nov; 13(11):1765-1772. PubMed ID: 27693265
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of prolactinoma in two male-to-female transsexual subjects following high-dose cross-sex hormone therapy.
Cunha FS; Domenice S; Câmara VL; Sircili MH; Gooren LJ; Mendonça BB; Costa EM
Andrologia; 2015 Aug; 47(6):680-4. PubMed ID: 25059808
[TBL] [Abstract][Full Text] [Related]
13. Prolactin-producing pituitary adenoma in a male-to-female transsexual patient with protracted estrogen administration. A morphologic study.
Kovacs K; Stefaneanu L; Ezzat S; Smyth HS
Arch Pathol Lab Med; 1994 May; 118(5):562-5. PubMed ID: 8192565
[TBL] [Abstract][Full Text] [Related]
14. Testosterone therapy for transgender men.
Irwig MS
Lancet Diabetes Endocrinol; 2017 Apr; 5(4):301-311. PubMed ID: 27084565
[TBL] [Abstract][Full Text] [Related]
15. Young adult psychological outcome after puberty suppression and gender reassignment.
de Vries AL; McGuire JK; Steensma TD; Wagenaar EC; Doreleijers TA; Cohen-Kettenis PT
Pediatrics; 2014 Oct; 134(4):696-704. PubMed ID: 25201798
[TBL] [Abstract][Full Text] [Related]
16. Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: A cohort study.
Vita R; Settineri S; Liotta M; Benvenga S; Trimarchi F
Maturitas; 2018 Jan; 107():92-96. PubMed ID: 29169588
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy: A Narrative Review.
Streed CG; Harfouch O; Marvel F; Blumenthal RS; Martin SS; Mukherjee M
Ann Intern Med; 2017 Aug; 167(4):256-267. PubMed ID: 28738421
[TBL] [Abstract][Full Text] [Related]
18. Body composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective case-controlled study (ENIGI).
Van Caenegem E; Wierckx K; Taes Y; Schreiner T; Vandewalle S; Toye K; Lapauw B; Kaufman JM; T'Sjoen G
Eur J Endocrinol; 2015 Feb; 172(2):163-71. PubMed ID: 25550352
[TBL] [Abstract][Full Text] [Related]
19. [Our experience with hormonal therapy in transsexual patients].
Weiss V; Weiss P; Fifková H
Vnitr Lek; 2015 Mar; 61(3):197-201. PubMed ID: 25873114
[TBL] [Abstract][Full Text] [Related]
20. [Role of hormones in sexual dysfunctions, homosexuality, transsexualism and deviant sexual behavior: diagnostic and therapeutic consequences].
Buvat J; Lemaire A; Ratajczyk J
Contracept Fertil Sex; 1996 Nov; 24(11):834-46. PubMed ID: 8991588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
